Matches in Wikidata for { <http://www.wikidata.org/entity/Q33437640> ?p ?o ?g. }
- Q33437640 description "2016 nî lūn-bûn" @default.
- Q33437640 description "2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q33437640 description "2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված" @default.
- Q33437640 description "2016年の論文" @default.
- Q33437640 description "2016年論文" @default.
- Q33437640 description "2016年論文" @default.
- Q33437640 description "2016年論文" @default.
- Q33437640 description "2016年論文" @default.
- Q33437640 description "2016年論文" @default.
- Q33437640 description "2016年论文" @default.
- Q33437640 description "2016年论文" @default.
- Q33437640 description "2016年论文" @default.
- Q33437640 description "2016年论文" @default.
- Q33437640 description "2016年论文" @default.
- Q33437640 description "2016年论文" @default.
- Q33437640 description "2016년 논문" @default.
- Q33437640 description "article científic" @default.
- Q33437640 description "article scientific" @default.
- Q33437640 description "article scientifique (publié 2016)" @default.
- Q33437640 description "articol științific" @default.
- Q33437640 description "articolo scientifico" @default.
- Q33437640 description "artigo científico (publicado na 2016)" @default.
- Q33437640 description "artigo científico (publicado na 2016)" @default.
- Q33437640 description "artigo científico" @default.
- Q33437640 description "artikull shkencor" @default.
- Q33437640 description "artikulong pang-agham" @default.
- Q33437640 description "artykuł naukowy" @default.
- Q33437640 description "artículo científico publicado en 2016" @default.
- Q33437640 description "artículu científicu espublizáu en 2016" @default.
- Q33437640 description "bilimsel makale" @default.
- Q33437640 description "bài báo khoa học" @default.
- Q33437640 description "mokslinis straipsnis" @default.
- Q33437640 description "naučni članak" @default.
- Q33437640 description "scienca artikolo" @default.
- Q33437640 description "scientific article" @default.
- Q33437640 description "teaduslik artikkel" @default.
- Q33437640 description "tieteellinen artikkeli" @default.
- Q33437640 description "tudományos cikk" @default.
- Q33437640 description "vedecký článok" @default.
- Q33437640 description "vetenskaplig artikel" @default.
- Q33437640 description "videnskabelig artikel (udgivet 2016)" @default.
- Q33437640 description "vitenskapelig artikkel" @default.
- Q33437640 description "vitskapeleg artikkel" @default.
- Q33437640 description "vědecký článek" @default.
- Q33437640 description "wetenschappelijk artikel" @default.
- Q33437640 description "wissenschaftlicher Artikel" @default.
- Q33437640 description "επιστημονικό άρθρο" @default.
- Q33437640 description "мақолаи илмӣ" @default.
- Q33437640 description "мақолаи илмӣ" @default.
- Q33437640 description "наукова стаття, опублікована в грудні 2016" @default.
- Q33437640 description "научна статия" @default.
- Q33437640 description "научная статья" @default.
- Q33437640 description "научни чланак" @default.
- Q33437640 description "научни чланак" @default.
- Q33437640 description "מאמר מדעי" @default.
- Q33437640 description "سائنسی مضمون" @default.
- Q33437640 description "مقالة علمية" @default.
- Q33437640 description "مقالهٔ علمی" @default.
- Q33437640 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33437640 description "บทความทางวิทยาศาสตร์" @default.
- Q33437640 description "სამეცნიერო სტატია" @default.
- Q33437640 name "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 name "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 name "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 type Item @default.
- Q33437640 label "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 label "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 label "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 prefLabel "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 prefLabel "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 prefLabel "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 P1433 Q33437640-53ED3F92-6935-4C20-A6E2-338E1373C417 @default.
- Q33437640 P1476 Q33437640-738E8418-A860-4426-8309-0FE329309FDB @default.
- Q33437640 P2093 Q33437640-143587B9-4590-4A69-A333-CEF9934F58E3 @default.
- Q33437640 P2093 Q33437640-17D39932-E513-4D8E-BE72-1F01C4999A58 @default.
- Q33437640 P2093 Q33437640-386E4110-349A-42F1-8713-EF19E8F4891E @default.
- Q33437640 P2093 Q33437640-BDD61464-58A6-4FED-B377-9B95F1EBC88F @default.
- Q33437640 P2093 Q33437640-E9A54C14-C8CC-4210-868D-8EE509D92F92 @default.
- Q33437640 P2093 Q33437640-F97EF1A0-DF4F-440E-B704-4626ABA3A3DB @default.
- Q33437640 P304 Q33437640-DCA05734-3A3C-4A4F-85E7-F5D706FFA16D @default.
- Q33437640 P31 Q33437640-036324B1-F4DD-44ED-AB60-9E8CE73908F8 @default.
- Q33437640 P356 Q33437640-6D189B7D-21B7-4023-A7C5-DFEE7F160FCA @default.
- Q33437640 P433 Q33437640-EDC6F196-E381-498E-B682-8A0454799A95 @default.
- Q33437640 P478 Q33437640-C5638DA9-2A72-40C4-8598-6FDE276CB0C1 @default.
- Q33437640 P50 Q33437640-275B61A8-A010-49EF-BB77-440A35C6DFCD @default.
- Q33437640 P50 Q33437640-2E317D6D-EA2E-4A60-BFF3-4F185FF05A79 @default.
- Q33437640 P50 Q33437640-351BA4AC-D739-4AE8-A30C-214C0D85678A @default.
- Q33437640 P50 Q33437640-90D9B938-871D-473C-912B-23A36F7CAFF0 @default.
- Q33437640 P50 Q33437640-960244E9-665D-46FE-8DE3-C7AFF9DBE6FB @default.
- Q33437640 P50 Q33437640-FD031DEF-6071-4585-B6C9-082984703A7F @default.
- Q33437640 P577 Q33437640-8B3460D5-7BF2-410B-A45A-AE6FEDE03CA6 @default.
- Q33437640 P698 Q33437640-19C3E17B-7D7A-4324-9051-D810782DDC9E @default.
- Q33437640 P921 Q33437640-F6595054-9935-42CE-8BBE-EF4483B28F48 @default.
- Q33437640 P356 CAD.0000000000000457 @default.
- Q33437640 P698 27977433 @default.
- Q33437640 P1433 Q4774128 @default.
- Q33437640 P1476 "Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas" @default.
- Q33437640 P2093 "Antoine Hollebecque" @default.
- Q33437640 P2093 "Arturo Soto-Matos" @default.
- Q33437640 P2093 "Gilles Salles" @default.